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IntroductIon
TCR signaling during thymic development directs critical 
cell fate decisions that select a functional, self-tolerant, and di-
verse T cell repertoire. The mature T cell repertoire is largely 
determined at the CD4CD8 double-positive (DP) thymocyte 
stage, dictated by the affinity of the interaction between the 
TCR and self-peptides bound to MHC (pMHC) molecules. 
Low affinity interactions generate signals that promote sur-
vival and maturation to the CD4 or CD8 single-positive (SP) 
stages of thymocyte development, whereas high affinity inter-
actions of the TCR with pMHC generate signals leading to 
cell death by negative selection. Additionally, several CD4SP 
thymocytes receiving relatively strong signals through their 
TCRs escape deletion and differentiate into regulatory T (T 
reg) cells (Starr et al., 2003; Hogquist and Jameson, 2014). 
Thus, the signaling intensity of the TCR signal must be prop-
erly regulated to be reflective of its recognition of pMHC.
The signal transduction machinery downstream of 
TCR and its regulation play important roles in the various 
thymocyte developmental outcomes and in peripheral T cell 
responses. One of the key proteins of the TCR signaling ma-
chinery is Zap70, a cytoplasmic tyrosine kinase. The impor-
tance of Zap70 is highlighted by loss-of-function mutations, 
which lead to impaired T cell development and immune de-
ficiency states in mice and in humans (Wang et al., 2010). Hy-
pomorphic alleles can lead to systemic autoimmune disease 
phenotypes (Sakaguchi et al., 2003; Siggs et al., 2007). In ad-
dition to Zap70, the Src family kinase Lck is critical to TCR 
signaling. Lck initiates TCR downstream signaling events 
by phosphorylating paired tyrosines in the immunoreceptor 
tyrosine-based activation motifs (ITAMs) of the CD3 and ζ 
chains, as well as by phosphorylating and activating Zap70. 
The full activation of Zap70 initiates TCR downstream sig-
nals that depend on its phosphorylation of two adaptor pro-
teins, linker of activated T cells (LAT) and SLP-76, which are 
required for increases in intracellular calcium and activation 
of the Ras–MAP kinase pathway (Smith-Garvin et al., 2009).
The proper regulation of Zap70 activity is critically im-
portant. In the ITAM-unbound state, Zap70 is presumed to 
be in an autoinhibited conformation in the cytoplasm. The 
crystal structure of nonphosphorylated Zap70 has revealed 
the basis of this autoinhibited conformation (Deindl et al., 
2007, 2009; Yan et al., 2013). Its N-terminal tandem SH2 do-
mains are misaligned for ITAM binding and are separated by 
interdomain A, which forms three helices behind the SH2 
domains that interact with the back of the inactive confor-
mation of the kinase domain and with sequences in interdo-
main B that links the C-terminal SH2 domain to the N-lobe 
of the kinase domain. Interdomain B contains two tyrosines, 
Y315 and Y319, which participate in Zap70 autoinhibition. 
In their unphosphorylated states, Y315 participates in hydro-
phobic interactions with W131 in interdomain A, whereas 
Y319 interacts with the N-lobe of the catalytic domain (Yan 
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et al., 2013). These hydrophobic interactions involving these 
two tyrosines are essential for full autoinhibition. Phosphory-
lation of these tyrosines by Lck is important for stabilizing the 
active conformation of the kinase and for the recruitment of 
important effector molecules.
For normal function of Zap70, the autoinhibited con-
formation is believed to be relieved in two steps based on 
mutagenesis studies and by recent hydrogen-deuterium ex-
change studies (Brdicka et al., 2005; Deindl et al., 2009; Yan 
et al., 2013; Klammt et al., 2015). The first step occurs when 
Zap70 is recruited to the TCR complex via high affinity in-
teraction of its tandem N-terminal SH2 domains with doubly 
phosphorylated ITAMs. The alignment of the tandem SH2 
domains upon phospho-ITAM binding is associated with 
a rotation and straightening of two of the helices in inter-
domain A, which is predicted to destabilize interactions be-
tween W131 and Y315 and other hydrophobic interactions, 
leading to increased accessibility of Y315 and Y319 to Lck. 
These latter events enable the second step of activation, in 
which Lck phosphorylates Y315 and Y319 in interdomain B, 
as well as Y493 in the activation loop of catalytic domain. 
The second step results in the adoption of the catalytically 
active conformation and full activation of the Zap70 kinase. 
This discrete two-step process of activation likely explains the 
finding of unphosphorylated Zap70 being bound to phos-
phorylated TCR ζ chain ITAMs in ex vivo thymocytes and 
T cells, a consequence of TCR interactions with endogenous 
self-pMHC molecules (van Oers et al., 1994; Witherden et al., 
2000; Mandl et al., 2013; Persaud et al., 2014). Thus, recruit-
ment of Zap70 to the TCR can precede its full activation.
The importance of the autoinhibited conformation 
is highlighted by the Lck-independent activation of Zap70 
in heterologous 293T cells or with recombinant proteins 
when either Y315 and Y319 or W131 are mutated to alanine 
(Deindl et al., 2007, 2009). Expression of the W131A mu-
tant in Zap70-deficient Jurkat cells results in hyperrespon-
siveness to TCR stimulation. Therefore, the autoinhibited 
conformation could safeguard the T cell from inappropriate 
activation that could lead to autoimmunity. Indeed, a recent 
report of a family with two affected children with profound 
multisystem, tissue-specific autoimmune disease showed 
disease resulted from inheritance of a hypomorphic muta-
tion and a weak hypermorphic mutation in Zap70 that de-
stabilized the autoinhibited conformation by disrupting the 
interaction of Y319 with the N-lobe of the kinase (Chan et 
al., 2016). However, mechanistic insights into how the com-
bination of the hypomorphic and the activating mutants 
of Zap70 lead to autoimmune disease is unclear. Further, 
no in vivo investigations of how a Zap70-activating allele 
influences thymic selection and immune tolerance mecha-
nisms have been performed.
In this study, we examined the importance of Zap70 au-
toinhibition in T cell development and in T cell function by 
destabilizing the autoinhibitory conformation of Zap70. We 
generated Zap70 W131A mutant mice carrying this semi-
active Zap70 kinase. When introduced into the OTII TCR 
transgenic (tg) background, the W131A mutation led to thy-
mocyte negative selection and resulted in impaired periph-
eral T cell signaling and responses. The hyporesponsiveness of 
peripheral T cells in W131AOT II mice shared features with 
T cell anergy, as indicated by increased expression of several 
anergy-related genes. Striking induction of inhibitory recep-
tors in W131AOT II T cells at least partially accounted for the 
peripheral T cell hyporesponsiveness. Together, these findings 
highlight the importance of autoinhibition of Zap70 and pro-
vide insights into how negative regulatory mechanisms in-
duced to compensate for increased TCR signaling can also 
lead to T cell hyporesponsiveness.
reSultS
relatively normal t cell development 
in the Zap70 W131A mice
To examine the importance of Zap70 autoinhibition in TCR 
signaling, we generated a knock-in mouse with the W131A 
mutation in interdomain A of the zap70 gene (Fig.  1  A). 
By intracellular staining, we found that the W131A substi-
tution caused an ∼50% reduction of Zap70 protein in the 
thymocytes and peripheral T cells of homozygous W131A 
mice (unpublished data). Despite lower Zap70 expression in 
W131A mice, T cell numbers and development were com-
parable in young WT and W131A mice (Fig. 1, B and C). 
There were no substantial differences in overall cellularity in 
the thymi, spleens, and LNs in W131A mice relative to WT 
littermates (Fig. 1 C and not depicted). However, we con-
sistently noted an increase in the CD4 T effector/memory 
(CD62LlowCD44high) cell population in young W131A mice 
that increased in older mice (Fig. 1 D). In addition, W131A 
mice had more peripheral Foxp3+ T reg cells than did their 
age-matched wild-type littermates (Fig. 1 E). This moderate 
increase in T reg cells occurred irrespective of age (range from 
6 wk to 8 mo; Fig. 1 E). However, no increase in thymic T reg 
cells was noted (unpublished data).
We next assessed whether TCR-induced downstream 
signaling events and activation responses were altered in 
W131A T cells. Direct characterization of Zap70 and LAT 
phosphorylation did not reveal substantial differences in 
anti-CD3-induced phosphorylation of either protein (un-
published data). In addition, both W131A and WT T cells 
had similar kinetics and amplitudes of calcium increases 
and ERK phosphorylation in response to varying doses of 
anti-CD3 stimulation (Fig. 1, F and G). Moreover, down-
stream activation responses of W131A primary T cells to 
TCR stimulation, such as CD69 up-regulation, appeared 
unaffected in comparison with WT T cells (unpublished 
data). Collectively, our findings suggest that in mice with 
a polyclonal TCR repertoire, the W131A mutation was as-
sociated with no detectable changes in T cell development 
and no obvious impairment in TCR-induced activation, al-
though there were increases in peripheral T reg cells and 
memory/effector cells over time.
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Figure 1. W131A mice with a polyclonal tcr repertoire have grossly normal t cell development and tcr signaling. (A) Targeting strategy used 
to produce W131A knock-in mice. Residue W131A present in exon 2 was mutated to alanine. (B) CD4 versus CD8 profiles of thymocytes (top) and LN cells 
(bottom) from WT and W131A mice. Numbers in quadrants are the percentages of each T cell subset. Results are representative of seven experiments. (C) 
Total cell numbers in thymi (top) and LN (bottom) in age-matched 2-mo-old WT and W131A mice. (D) Increased percentages of memory (CD62LloCD44hi) 
CD4+ T cells in W131A mice (n = 5 per group). All error bars represent SEM. *, P < 0.05; **, P < 0.01. (E) Comparison of CD4+Foxp3+ T cells from LNs of WT 
and W131A mice of the indicated ages (n = 4 per group). (F) Anti–CD3-induced calcium changes in DP thymocytes (top), CD4SP (middle), and CD8SP thy-
mocytes (bottom) from WT and W131A mice. (G) DP, CD4SP, and CD8SP thymocytes from WT or W131A mice were analyzed for levels of phospho-ERK by 
flow cytometry. Unstimulated T cells (filled gray) and anti-CD3–stimulated T cells (2.5 min) from WT mice (red line), and W131A (blue line) are shown. Data 
are representative of three experiments.
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Profound developmental defect in tcr tg W131A mice
The increase in memory/effector T cells in the setting of 
grossly normal T cell development in W131A mice suggested 
that some compensatory mechanisms, such as a TCR reper-
toire shift, might mask the previously observed effect of the 
W131A mutation on TCR signaling. To test this, we intro-
duced the OTII TCR transgene into the W131A background 
and analyzed the impact of the mutation on positive and 
negative selection of thymocytes bearing a single TCR spec-
ificity. In contrast to W131A mice with a polyclonal TCR 
repertoire, the number and percentage of CD4SP thymocytes 
were greatly reduced in W131AOT II mice (Fig. 2, A, top, and 
B). Moreover, a smaller percentage of Vα2 clonotype-pos-
itive CD4SP thymocytes were generated in W131AOT II 
mice compared with wild-type littermates (Fig. 2 A, bot-
tom). Consistent with a decrease in the CD4SP population, 
we found that the generation of mature peripheral CD4+ 
T cells was also impaired in W131AOT II mice (Fig.  2, B 
and C, top). Most peripheral CD4+ T cells in wild-type lit-
termates exhibited a naive phenotype (CD62LhighCD44low), 
whereas the increased peripheral CD4+ T cells from young 
adult W131AOT II mice exhibited a phenotype typical of 
effector/memory cells (CD62LlowCD44high; Fig.  2  C, bot-
tom). Moreover, CD69, an early activation marker, was found 
more frequently on peripheral CD4+ T cells in W131AOT II 
mice (unpublished data). As the total number of thymocytes 
and peripheral CD4+ T cells were markedly reduced, it is 
possible that the abnormal phenotype of peripheral CD4+ 
T cells from W131AOT II mice resulted from activation by 
endogenous antigens or by the lymphopenic environment.
enhanced generation of t reg cells in W131Aot II mice
Despite a lower number of transgene-positive CD4+ T 
cells in W131AOT II mice, the generation of Foxp3+ T 
reg cells was substantially increased in the thymus and in 
the periphery of W131AOT II mice relative to OTII con-
trols (Fig.  2  D). The strength of TCR signaling has been 
reported to determine the fate of CD4SP thymocytes. Al-
though those CD4SP thymocytes receiving the strongest 
TCR signal are deleted, thymocytes receiving TCR signals 
of more moderate strength escape deletion but differentiate 
into Foxp3+ T reg cells (Josefowicz et al., 2012). Thus, our 
results suggest that the W131A mutation in Zap70 leads to 
loss of autoinhibition, leading to stronger TCR-mediated 
signaling, thereby preferentially favoring the generation of T 
reg lineage cells. In addition to the T reg cells, we also ex-
amined whether the development of other nonconventional 
αβT cell lineages, such as iNKTs and γδ T cells, might be 
affected. However, we found no differences in the numbers 
of iNKT or γδ lineage T cells in the thymus or periphery of 
W131AOT II mice (unpublished data).
We compared the suppressive abilities of W131AOT II 
T reg cells with those of OTII T reg cells in vitro. W131AOT 
II T regs inhibited the proliferation of WT naive cells stim-
ulated with anti-CD3 as efficiently as did OTII T reg cells 
(unpublished data). Therefore, the T reg cell populations are 
Figure 2. restricting the tcr repertoire in 
W131A mice leads to a profound impair-
ment in t cell development. (A) Represen-
tative plots showing expression of CD4/CD8 
(top) and OTII TCR tg (bottom) in total thymo-
cytes from OTII and W131AOT II mice. Num-
bers in each histogram of the bottom panels 
indicate the frequency of OTII (Vα2+) tg-pos-
itive cells in CD4SP thymocytes. (B) Absolute 
numbers of CD4+ T cells from thymi and LNs of 
either OTII or W131AOT II are shown (n = 10 per 
genotype). All error bars represent SEM. ***, P < 
0.001; ****, P < 0.0001. (C) Representative plots 
showing expression of CD4/CD8 (top) and 
CD62L/CD44 (bottom) in LN cells from OTII and 
W131AOT II mice. (D) Representative flow cyto-
metric profiles of CD4 and Foxp3 expression in 
CD4 SP thymocytes (top) and peripheral CD4+ 
T cells (bottom) from OTII and W131AOT II mice. 
Data are representative of seven experiments.
837JEM Vol. 214, No. 3
substantially expanded in the W131AOT II mice and appear 
to exhibit normal suppressive function.
Increased apoptosis in dP thymocytes in W131Aot II mice
In light of the enhanced generation of T reg cells in 
W131AOT II mice, which is suggestive of increased TCR 
signaling, we investigated the possibility that DP thymocytes 
from W131AOT II mice might be undergoing negative selec-
tion. We first assessed activation-induced cell death in vitro. 
Thymocytes from either W131OTII or OTII mice were stim-
ulated overnight with medium or plate-bound anti-CD3 plus 
anti-CD28 in vitro, and expression of Bim, a pro-apoptosis 
Bcl2 family member, was assessed. The percentages of Bim+ 
cells were significantly increased in the stimulated DP thymo-
cytes from W131OTII mice when compared with those from 
OTII mice (Fig.  3 A). To extend our in vitro findings, we 
induced apoptosis of thymocytes by i.p. injecting mice with 
a low dose of anti-CD3 mAb (Kishimoto and Sprent, 1997). 
Consistent with the in vitro data, fewer viable DP thymocytes 
from W131AOT II mice were recovered 20 h after anti-CD3 
injection compared with DP thymocytes from OTII mice 
(Fig. 3 B). Collectively, our in vitro and in vivo data strongly 
argue for an increased sensitivity to TCR-induced apoptosis 
of W131AOT II DP thymocytes.
To determine whether increased negative selection could 
account for the reduction of OTII+ CD4SP thymocytes in 
W131AOT II mice, we crossed W131OTII and OTII mice to 
a tg line expressing a human Bcl-2 transgene under the control 
of the proximal lck promoter. As shown in Fig. 3 C, overex-
pression of the Bcl-2 protein had a minimal effect on pro-
moting the survival of OTII tg+ CD4SP thymocytes in OTII 
mice, although we noted an increase in CD8SP thymocytes as 
was reported previously (Sentman et al., 1991). Interestingly, a 
more than threefold increase in the number of OTII+ CD4SP 
thymocytes was observed in W131AOT II mice expressing the 
Bcl-2 transgene compared with age-matched W131AOT II 
mice (Fig. 3, C and D). Further analysis of OTII+ CD4SP thy-
mocytes revealed that a greater proportion of CD4SP thymo-
cytes in W131AOT II mice with the Bcl-2 tg expressed CD25 
on their surface (Fig. 3 E). Co-staining with Foxp3 antibody 
showed that the majority of CD4+CD25+ thymocytes were 
not T reg cells, suggesting that they were activated but were res-
cued by overexpression of Bcl-2 (Fig. 3, E–G). Although OTII 
mice expressing the Bcl-2 tg also showed an elevated percent-
age of CD25+Foxp3neg CD4SP thymocytes, the extent of the 
increase was not nearly as profound as the positive selection in 
the W131AOT II mice with or without the Bcl-2 transgene 
(Fig. 3, E and G). Together, we conclude that enhanced nega-
tive selection may explain the unexpected decrease in OTII+ 
CD4SP thymocytes in W131AOT II mice.
the Zap70 W131A mutation results in 
increased tcr signaling
As increased T reg development and negative selection in 
W131AOT II mice are predicted to result from stronger TCR 
signals received by thymocytes during thymic development, 
we examined whether we could detect altered TCR sig-
naling strength in the context of the restricted OTII TCR 
repertoire. We took advantage of the Nur77-GFP reporter 
mouse to study the integrated TCR signal strength perceived 
by different thymocyte subsets (Zikherman et al., 2012). In 
line with previous studies (Moran et al., 2011; Zikherman 
et al., 2012), we found that in OTII mice, the Nur77-eGFP 
reporter was induced at the time of positive selection, i.e., 
Nur77 expression was low in preselection DP thymocytes and 
was up-regulated in postselection DP thymocytes (Fig. 4 A, 
black line). Interestingly, compared with OTII mice, the 
Nur77-GFP reporter expression in W131AOT II mice was 
more markedly increased in postselection DP and CD4SP 
thymocytes and in a larger proportion of the cells (Fig. 4 A, 
dashed line). This is suggestive of enhanced TCR signaling 
and consistent with the putative enhanced negative selection 
observed in W131OTII mice. As DP thymocytes matured to 
the CD4SP stage, GFP expression differences diminished but 
were still apparent between WT and W131A-expressing cells. 
Likewise, some OTII+, non–T reg cell peripheral T cells ex-
hibited higher GFP expression in the periphery, indicating 
that a fraction of T lineage cells perceive stronger TCR sig-
nals in W131AOT II mice.
To further study Nur77 induction after acute TCR 
stimulation in vitro, we stimulated thymocytes and CD4+ T 
cells ex vivo with a combination of anti-CD3 and -CD28 
for 3 h and assessed Nur77-GFP expression in DP, CD4SP 
thymocytes, and peripheral CD4+ T cells (Fig. 4 B). A greater 
proportion of DP and CD4 SP thymocytes isolated from 
W131AOT II mice up-regulated Nur77 expression and did so 
to a greater extent more than did thymocytes from OTII mice. 
Collectively, our findings suggested that W131AOT II thymo-
cytes and peripheral CD4+ T cells exhibited enhanced basal 
TCR signaling compared with OTII thymocytes and further 
up-regulated Nur77-GFP in response to TCR stimulation.
defective Il-2 production in W131Aot II 
mice and hyporesponsiveness
Because Nur77 GFP expression reflects integrated TCR 
downstream signaling over time (Au-Yeung et al., 2014), 
we next investigated whether other TCR-dependent events 
were enhanced in the peripheral T cells from W131AOT 
II mice. We measured IL-2 production and induction of 
activation markers, such as CD25 and CD69, as indicators 
of productive T cell activation. Sorted non–T reg cell and 
naive CD4+ T cells from OTII, Zap70+/−OTII (to control 
for lower Zap70 expression), or two W131AOT II mice 
were cultured in vitro for 16 h with APCs loaded with OVA 
323–339 peptide. As expected, a substantial proportion of 
naive CD4+ T cells from both OTII and Zap70+/−OTII 
mice secreted IL-2 after stimulation (Fig. 5 A). Additionally, 
both CD25 and CD69 were markedly up-regulated in these 
cells (Fig. 5, B and C). In contrast, the proportion of IL-2–
secreting CD4+ T cells from W131AOT II mice was greatly 
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reduced as were the induction of CD25 and CD69 after 
antigen stimulation (Fig. 5).
To assess whether T cell hyporesponsiveness in 
W131AOT II CD4+ T cell also occurs in vivo, we co-trans-
ferred fluorescent dye–labeled OTII and W131AOT II 
CD4+ T cells at a ratio of 1:1 into congenic hosts that were 
then immunized in the footpad with OVA protein. In vivo 
proliferative responses were measured by dye dilution. At 
72  h after immunization, we found that OTII CD4+ T 
cells underwent robust proliferation, whereas W131AOT II 
CD4+ T cells proliferated less to OVA protein (Fig.  5, D 
and E). Together, our data revealed a cell-intrinsic impaired 
response of the peripheral CD4+ T cells from W131AOT 
II mice to antigen, which contrasts with their higher TCR 
basal signaling detected by Nur77-GFP expression.
cd4+ t cells from W131Aot II mice 
displayed an anergic phenotype
The diminished responses of CD4+ T cells from W131AOT II 
mice led us to hypothesize that these peripheral CD4+ T cells 
might be anergic. We found the transcript levels of GRA IL, 
an E3 ubiquitin ligase implicated in anergy (Heissmeyer and 
Rao, 2004), from CD4+ T cells of W131AOT II mice were in-
creased by 4–5-fold compared with those of the control CD4+ 
Figure 3. evidence for enhanced negative selection in W131Aot II mice. (A) In vitro–induced apoptosis of OTII or W131AOT II DP thymocytes, ana-
lyzed by intracellular staining of Bim after 16 h of incubation in plate-bound anti-CD3 and anti-CD28. (B) In vivo injection of anti-CD3 to mimic negative 
selection. Age-matched OTII and W131AOT II mice were injected i.p. with 10 µg/ml of either PBS or anti-CD3 mAb. After 20 h, cell numbers of DP thymocytes 
were determined and were compared with animals injected with PBS. Data are pooled from two independent experiments with four mice per genotype. 
(C and E) Flow cytometry of thymocytes from thymi of OTII and W131AOT II mice with or without the lck-bcl2 transgene. (C) Representative plot showing 
CD4/CD8 profile of freshly isolated thymocytes from the indicated genotypes. (D) Quantification of absolute CD4SP cell counts from OTII and W131AOT 
II with or without lck-bcl2 transgene. n = 5 per genotype. (E) Expression of Foxp3 versus CD25 of CD4SP thymocytes from the indicated genotypes. Data 
shown are representative of three independent experiments. (F) Percentages of Foxp3+CD4SP thymocytes from the indicated genotypes. (G) Percentages of 
CD25+Foxp3neg CD4SP thymocytes from the indicated genotypes. n = 5 per genotype. All error bars represent SEM. NS, not significant; *, P < 0.05; **, P < 0.01.
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T cells (Fig. 6 A). Similarly, the expression of the Egr2 protein, 
implicated in T cell anergy (Safford et al., 2005), was elevated 
in W131AOT II cells (Fig. 6 B). Moreover, a recent study has 
shown that coexpression of CD73 and folate receptor 4 (FR4) 
defines a population of naturally occurring anergic T cells 
(Kalekar et al., 2016). This prompted us to investigate whether 
the CD73hiFR4hi anergic population might be increased in 
W131AOT II mice. Indeed, in both naive Foxp3negCD44lo and 
activated Foxp3negCD44hi CD4 T cells, we observed an increase 
in the CD73hiFR4hi anergic population in W131AOT II mice 
compared with OTII mice (Fig.  6 C, top and bottom). To-
gether, these results suggest that CD4+ T cells from W131AOT II 
mice may be diverted to an anergic state.
Striking up-regulation of inhibitory 
receptors in W131Aot II t cells
To reconcile the increased TCR signal strength observed in the 
thymus and the anergic-like phenotype in the periphery, we 
examined the surface expression of several inhibitory receptors, 
which have been shown to dampen downstream TCR signal-
ing and cause T cell unresponsiveness (Rodriguez-Manzanet 
et al., 2009; Odorizzi and Wherry, 2012). In OTII thymocytes, 
PD-1 expression is low at the DP stage (unpublished data). In 
contrast, we were able to readily detect PD-1 expression on 
post-positive selection DP thymocytes in W131AOT II mice 
(Fig. 6 D, top). More strikingly, PD-1 expression was further 
up-regulated on CD4SP thymocytes from W131AOT II mice 
(Fig. 6 D, top). Whereas PD-1 expression was hardly detectable 
in OTII peripheral CD4+T cells, PD-1 expression was ele-
vated on a substantial subset of the peripheral CD4+ T cells in 
W131AOT II mice, particularly of the memory/effector subset 
(Fig. 6 D, top). Similar to PD-1, we also found that the expres-
sion of another inhibitory receptor, Tim-3 (Fig. 6 D, bottom), 
was up-regulated on W131AOT II thymocytes and peripheral 
T cells (Fig. 6 D, bottom). Of note, we found that T cells iso-
lated from W131A mice with a polyclonal TCR repertoire also 
expressed higher levels of PD-1 compared with T cells from 
wild-type controls (unpublished data). Among other known 
inhibitory receptors that we screened, CTLA-4, LAG3, and 
TIG IT were not up-regulated on W131AOT II T cells (unpub-
lished data). Interestingly, we also found that the majority of 
the CD73hiFR4hi anergic population in W131AOT II mice was 
contained in the PD-1+ T cell subset, whereas PD-1− T cells ex-
hibited very little enrichment of this population (Fig. 7 E). This 
was consistent with the previous study that found that PD-1 
was one of the genes that was enriched in the CD73hiFR4hi an-
ergic T cell population (Kalekar et al., 2016). Overall, these data 
suggest that several negative regulatory mechanisms, including 
the expression inhibitory receptors, are induced in response to 
enhanced TCR signaling in W131AOT II mice.
the increase in t reg cells and up-regulation of Pd-1 on 
W131Aot II cd4+ t cells are cell intrinsic
To address whether the increase in the T reg cell population 
and increase in PD-1+ cells in W131AOT II mice were cell- 
intrinsic or a consequence of the lymphopenic environment, 
we generated mixed bone marrow chimeras in which OTII 
and W131AOT II bone marrow cells with different congenic 
Figure 4. evidence for enhanced tcr sig-
naling in W131Aot II mice. (A) Assessment 
of Nur77-GFP fluorescence in freshly iso-
lated thymic subsets or T cells from OTII and 
W131AOT II harboring the Nur77-GFP reporter. 
DP thymocytes were further subdivided into 
preselection (CD5int TCRβint) and post-selec-
tion (CD5hiTCRβhi) stages based on CD5 and 
TCR expression (B) Thymocytes or peripheral 
CD4+ T cells from OTII and W131AOT II harbor-
ing the Nur77-GFP reporter were stimulated 
with plate-bound anti-CD3 and anti-CD28 for 
3 h, and then analyzed by flow cytometry to 
assess Nur77-GFP fluorescence in preselection 
and post-selection DP and CD4SPCD25-Vα2+ 
thymocytes and CD4+CD25-Va2+ T cells. Data 
shown are representative of three experiments.
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markers were transferred at a 1:1 ratio into lethally irradiated 
hosts. As shown in Fig. 7 A, we observed approximately equal 
representation of OTII and W131AOT II thymocytes at the 
DN and DP stages. In striking contrast, significantly fewer 
CD4SP thymocytes and peripheral CD4+CD25− T cells 
were generated from W131AOT II bone marrow cells than 
from OTII mice (Fig. 7 A). This finding is consistent with 
the developmental defect seen in the intact W131OTII mice 
(Fig. 2 C), suggesting that the defective generation of CD4SP 
thymocytes and CD4+ T cells in the periphery in W131AOT II 
mice is cell intrinsic. Despite W131AOT II CD4 T cells hav-
ing a developmental disadvantage in the periphery, in con-
trast to the OTII T cells, the enhanced generation of T reg 
cell population and the up-regulation of PD-1 were still seen 
on the W131AOT II T cells in the chimeric mice (Fig. 7, B 
and C). Together, these data suggest that these phenotypes 
are likely caused by enhanced cell-intrinsic TCR signaling in 
W131OTII mice rather than the lymphopenic environment.
Figure 5. Peripheral cd4+ t cells from W131Aot II mice are hyporesponsive to antigen challenge. Naive CD4+ T cells from W131OTII mice exhibit 
impaired IL-2 production (A) and defective up-regulationof CD25 (B) and CD69 (C). (A–C) Sorted naive CD4+ T cells from age-matched OTII, Zap70+/−OTII, 
and two W131AOT II mice were cultured in vitro with splenocytes from TCRα−/− mice and 1 µM OVA peptide for 16 h. Cells were subsequently stained for 
the indicated activation markers or secreted IL-2. Results are representative of two independent experiments with two to three mice for each genotype. (D) 
Proliferative responses of OTII and W131AOT II CD4+ T cells after antigen challenge in vivo. CD4+CD25− T cells from OTII and W131AOT II mice were loaded 
with CFSE and violet cell trace (VCT) dyes, respectively. Cells, mixed at a 1:1 ratio, were adoptively transferred into CD45.1+ congenic hosts. Host mice were 
immunized the next day with 25 µg OVA protein in complete Freund’s adjuvant. Dilution of cell trace dyes was measured by flow cytometry 3 d after immu-
nization. Results are representative of three independent experiments with nine mice in each genotype. (E) Division index of in vivo proliferative response 
from draining LN cells. All error bars represent SEM. ****, P < 0.0001.
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Higher basal tcr signaling but diminished inducible 
signaling in W131Aot II t cells
Previous studies have shown that PD-1 exerts its inhibitory 
function by antagonizing TCR downstream signaling (Shep-
pard et al., 2004; Yokosuka et al., 2012). To examine the ef-
fect of up-regulation of inhibitory receptors upon TCR 
signaling, we assayed TCR-induced calcium increases and 
ERK phosphorylation in cells from these mice (Fig. 8). Un-
like the W131A mutant in Jurkat cells, which exhibited hy-
perresponsiveness to TCR simulation (Deindl et al., 2009), 
CD4SP thymocytes from W131AOT II mice displayed lower 
calcium increases in response to anti-CD3 cross-linking. The 
TCR-induced calcium response was even further reduced in 
peripheral CD4+ naive and memory T cells from W131AOT 
II mice (Fig.  8  A). We also observed slightly lower anti- 
CD3–induced ERK phosphorylation in W131AOT II DP 
and CD4SP thymocytes compared with OTII thymocytes 
(Fig. 8 B). In contrast, in peripheral CD4+ T cells, ERK phos-
phorylation in response to anti-CD3 was markedly reduced 
from W131AOT II T cells when compared with OTII thy-
mocytes (Fig. 8 C, top). Interestingly, although TCR-induced 
responses were greatly diminished in W131AOT II CD4+ T 
cells, both free cytoplasmic calcium concentrations and Erk 
phosphorylation were reproducibly elevated in the resting, 
Figure 6. Peripheral cd4+ t cells from W131Aot 
II mice display an anergic phenotype. (A) Increased 
mRNA expression of GRA IL in naive CD4+OTII+ periph-
eral T cells from W131AOT II mice. Data are pooled from 
two independent experiments (n = 4 per genotype). (B) 
Increased expression of the Erg2 transcription factor in 
naive CD4+OTII+ peripheral T cells from W131AOT II mice. 
Results are representative of two independent exper-
iments with three mice in each genotype. (C) CD44low 
(naive, top) and CD44high (memory/activated, bottom) 
splenocytes from either 2-mo-old OTII or W131AOT II 
mice were stained for CD73 and FR4 on CD4+ Foxp3neg T 
cells. Percentages in CD73hiFR4hi gate are shown. Results 
are quantified (right) for CD44low (top) and CD44high (bot-
tom) cells of the indicated genotypes. (D) Flow cytometric 
analysis of expression of indicated inhibitory receptors 
at various stages of thymic development and naive or 
memory LN T cells. Data shown are representative of four 
independent experiments. (E) Comparison of frequency 
of CD4+Foxp3negCD44hiCD73hiFR4hi T cells in PD-1+ and 
PD-1− populations from W131AOT II splenocytes. Data are 
pooled from 2 independent experiments with four mice 
per genotype. All error bars represent SEM. *, P < 0.05; **, 
P < 0.01; ***, P < 0.001.
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basal state (Fig.  8  A, left, C, bottom, and D). Others have 
reported an effect of PD-1 in down-regulating the TCR- 
induced AKT–mTOR pathway (Wherry and Kurachi, 2015). 
We examined TCR-induced activation of the AKT–mTOR 
pathway by assessing phosphorylation of AKT kinase and the 
direct mTORC1 substrate ribosomal protein S6 kinase in 
peripheral CD4+ T cells. Indeed, we found that the activa-
tion of the AKT/mTOR pathway appears to be attenuated 
in W131AOT II CD4+ T cells after stimulation by anti-CD3, 
as indicated by the reduced amounts of phospho-AKT and 
S6 kinases (Fig.  8  E, top and bottom). Moreover, reduced 
levels of AKT and S6 phosphorylation were also observed in 
the peripheral CD4+ from W131A mice with a polyclonal 
TCR repertoire (unpublished data). Collectively, our findings 
suggest that up-regulation of inhibitory receptors in W131A 
T cells correlates with higher basal signaling and a negative 
impact on several TCR-induced signaling pathways.
Anti–Pd-1 treatment partially reverses t cell 
unresponsiveness in W131Aot II mice
To determine whether up-regulated inhibitory receptors 
such as PD-1 could account for T cell unresponsiveness in 
the periphery of W131AOT II mice, we treated OTII and 
W131AOT II mice with anti–PD-1 mAb. We i.p. injected ei-
ther anti–PD-1 mAb (J43) or control IgG (hamster IgG) into 
mice three times a week for 3 wk, beginning at 4 wk of age. 
As shown in Fig.  9, we found no substantial difference in 
IL-2 production, or induction of activation markers compar-
ing OTII mice treated with either control IgG or anti–PD-1 
mAb. In contrast, anti–PD-1 mAb treatment in W131AOT II 
mice partially reversed T cell unresponsiveness as detected by 
increased IL-2 production and greater induction of CD25 
and CD69 after TCR stimulation. Together, we conclude that 
the PD-1 inhibitory pathway contributes to T cell hypore-
sponsiveness in W131AOT II mice.
dIScuSSIon
In the present study, we characterized a mouse model to eval-
uate whether altering Zap70 regulation by impairing its au-
toinhibition impacts T cell development or T cell function. 
The W131A mutation partially disrupts the autoinhibition of 
the Zap70 kinase. More specifically, this mutation bypasses the 
first step in relieving autoinhibition, a role played by phos-
pho-ITAM binding. However, we failed to detect changes 
in thymocyte development and only had subtle hints of per-
turbed T cell function (i.e., more effector/memory and T reg 
cells) in W131A mice with a diverse TCR repertoire. In the 
context of the OTII tg system, where compensation to in-
creased TCR signaling via repertoire shift was not possible, 
enhanced TCR signaling strength, a result of the W131A mu-
tation, was clearly revealed. Higher TCR signaling strength 
in W131AOT II mice was manifested most clearly by in-
creased expression of Nur77 in CD4 thymocytes and pe-
ripheral CD4+ T cells. With a fixed repertoire, this increased 
signaling perturbed thymocyte development, increasing the 
number of cells diverted to the T reg lineage or undergoing 
negative selection. Therefore, our results emphasize the im-
portance of tight control of Zap70 kinase activity and TCR 
signaling during T cell development. Increased signaling from 
cells with the W131A mutation in Zap70 led to additional 
Figure 7. Increase in t reg cells and elevated 
Pd-1 expression in W131Aot II cd4+ t cells are 
cell intrinsic. (A) Competitive repopulation of OTII 
and W131AOT II donor bone marrow cells, injected 
at a 1:1 ratio, was assessed in mixed bone marrow 
chimera 8 wk later. (B) Percentages of peripheral T 
reg cells (Foxp3+) generated from mixed bone mar-
row chimeras. (C) Percentages of PD-1+ CD4 T cells 
generated from mixed bone marrow chimeras. Data 
are representative of two independent experiments 
with six chimeras. All error bars represent SEM. **, P 
< 0.01; ***, P < 0.001.
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Figure 8. the W131A mutation results in increased basal signaling but diminished tcr-induced signaling. (A) Calcium responses of thymocytes 
and peripheral T cells in OTII and W131AOT II mice. Thymocytes or purified CD4+ T cells from both genotypes were first stained with anti-CD45 with different 
fluorochrome conjugates, mixed together, and loaded with Indo-1 to detect intracellular calcium. Cells were stimulated with 10 µg/ml anti-CD3, followed by 
cross-linking with 50 ng/ml anti–Armenian hamster IgG. (left) Basal calcium responses. Red and blue lines indicate OTII and W131AOT II, respectively. (B–D) 
Flow-based assessment of ERK phosphorylation. Thymocytes (B) or purified peripheral CD4+ T cells (C) were stimulated with anti-CD3 cross-linking for the 
indicated times. (C) Erk phosphorylation in peripheral CD4+ T cells was shown over time after stimulation (top). Overlay depicts one representative experi-
ment of basal Erk phosphorylation between OTII and W131AOT II CD4+T cells (bottom). (D) Quantification of mean fluorescence (MFI) of ERK phosphorylation 
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compensatory mechanisms within thymocytes and peripheral 
T cells that was manifested by up-regulation of inhibitory 
pathways that led to T cell hyporesponsiveness. Together, by 
altering TCR signaling, multiple levels of immune tolerance 
mechanisms were engaged.
In our previous cell line studies, Zap70-deficient Jurkat 
cells reconstituted with the W131A mutant exhibited hyper-
responsiveness, such as increased TCR-induced calcium re-
sponses and enhanced phosphorylation of LAT, PLCγ1, and 
ERK (Deindl et al., 2009). Unlike these cell line studies, no 
obvious signaling defects downstream of TCR were observed 
in the T cells from W131A mice with the polyclonal TCR 
repertoire. The difference in these results between Jurkat cells 
and T cells may reflect plasticity in the mouse cells to engage 
various levels of regulatory mechanisms, apparently not pos-
sible in Jurkat cells. One example is the likely repertoire shift 
that occurred in early thymocyte development manifested in 
cells with a diverse TCR repertoire. Although the compen-
satory mechanisms in mice resulted in relatively normal T 
cell development in W131A mice with a polyclonal reper-
toire, increased generation of the T reg cell population and of 
memory CD4+ T cells provides some evidence for enhanced 
TCR signaling. When the ability to compensate for increased 
TCR signaling via repertoire shift was eliminated by fixing 
the TCR repertoire, the majority of immature W131AOT II 
thymocytes with hyperresponsive TCR signaling were either 
deleted through negative selection or differentiated into the 
T reg cell lineage. In support of this notion, when the Bcl-2 
transgene was introduced into either OTII or W131AOT II 
mice, a greater proportion of Foxp3negCD4SP thymocytes 
expressing high levels of CD25 were rescued in W131AOT 
II mice as compared with OTII mice (Fig. 3). Additionally, 
W131AOT II DP thymocytes manifested a greater increase 
in Nur77 GFP induction than did OTII thymocytes in the 
basal state and when stimulated in vitro with anti-CD3 and 
anti-CD28 (Fig. 4). Together, these findings suggest that by 
fixing the TCR repertoire enhanced TCR signaling becomes 
evident during thymic selection.
As thymocytes matured, another negative feedback 
mechanism for increased TCR signaling was engaged and 
manifested in the W131A mice. Inhibitory receptors, such 
as PD-1 and Tim-3 that functionally down-regulate TCR- 
mediated pathways that were increased in the CD4SP thymo-
cytes of W131AOT II mice. PD-1 is primarily expressed on 
DN αβ and γδ T cells in the thymus (Okazaki et al., 2013). Its 
expression is rapidly down-regulated once thymocytes com-
plete β-selection and mature to the DP stage. The striking 
up-regulation of PD-1 at the CD4SP stage led us to postulate 
that these inhibitory receptors play a role in down-modu-
lating TCR signaling in more mature W131AOT II thymo-
cytes. Indeed, we provided evidence that the calcium, Erk, 
and AKT–mTOR pathways are attenuated in W131AOT II 
thymocytes after TCR stimulation. These results suggested 
that enhanced PD-1 expression in W131AOT II mice may 
modulate TCR signaling threshold in the thymus.
The role of PD-1 expression in the thymus has not 
been characterized as extensively as its role in the periphery. 
A previous study also demonstrated that PD-1 overexpression 
in the thymus inhibits positive selection in the HY TCR tg 
model by impairing thymocyte maturation, including CD69 
up-regulation (Keir et al., 2005). Interestingly, we began to 
observe up-regulation of PD-1 in post-selection (CD5high 
TCRβhigh) DP thymocytes in W131AOT II mice. It is possi-
ble that enhanced PD-1 expression has a negative impact on 
positive selection, thereby explaining the marked reduction of 
OTII+ CD4SP thymocytes in W131AOT II mice, in addition 
to the enhanced negative selection observed.
The impact of the increased TCR signaling resulting 
from the W131A mutation, leading to expression of inhibi-
tory receptor signaling, was also manifested in mature naive 
and memory peripheral T cells. Notably, W131AOT II CD4+ 
T cells showed a greater reduction in TCR signaling than 
did W131AOT II thymocytes. One possibility could be the 
intrinsic difference between peripheral CD4+ T cells and thy-
mocytes in their sensitivity to inhibitory receptor-mediated 
regulation. The other possibility is that anergy-associated pro-
teins, such as GRA IL (Whiting et al., 2011) and Egr2 (Safford 
et al., 2005) were up-regulated in peripheral CD4+ T cells. 
Thus, in addition to expression of the inhibitory receptors, 
additional down-modulation of TCR signaling was further 
enforced by increased expression of GRA IL and Egr2, result-
ing in dampened inducible signaling in W131AOT II CD4+ T 
cells. In support of this, we found that anti–PD-1 mAb treat-
ment only partially restored IL-2 production, suggesting that 
the hyporesponsiveness in W131AOT II CD4+ T cells resulted 
from multiple mechanisms and may involve integration of 
several negative regulatory pathways throughout T cell devel-
opment and in the periphery.
Whereas inducible TCR signaling in W131AOT II 
CD4+ T cells was greatly impaired, basal cytoplasmic free 
calcium and ERK phosphorylation were elevated. This is 
reminiscent of anergic B cells reported in the HEL- and 
Ars-specific BCR tg model systems (Cambier et al., 2007). 
In both BCR tg systems, high basal signaling is thought to 
result from chronically occupied BCR on anergic B cells. 
It is possible that, similar to anergic B cells, TCRs from 
W131AOT II T cells with hyperactive Zap70 kinase are ac-
tivated by chronic interaction with endogenous antigens. 
levels from the indicated genotypes is shown, illustrating higher basal ERK levels in W131AOT II T cells, compared with OTII T cells. n = 5 per genotype. All 
error bars represent SEM. **, P < 0.01. (E) Flow-based assessment of AKT (top) and S6 (bottom) phosphorylation. Purified CD4+ T cells from OTII and W131AOT 
II mice were stimulated with anti-CD3 cross-linking for 10 min. Phosphorylated-AKT and -S6 were assessed by intracellular staining. Data are representative 
of at least three independent experiments.
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In support of this, we observed higher GFP expression in 
W131AOT II T cells throughout thymocyte development 
and in the periphery, even though the cognate OVA anti-
gen was not expressed (Fig. 4 A). Together, these data suggest 
continuous recognition of some self-peptide-MHC class II 
in W131AOT II T cells contributes to the phenotypes ob-
served in the W131AOT II mice.
Our characterization of peripheral T cells in W131AOT II 
mice reveals many features that resemble other hyporespon-
sive states in T cells such as anergy (Mueller and Jenkins, 1995; 
Schwartz, 2003) and exhaustion (Wherry and Kurachi, 2015). 
For instance, the finding that W131AOT II CD4+ T cells failed 
to produce IL-2 efficiently or up-regulate CD69 and CD25 
after OVA peptide stimulation was very similar to what has 
been seen in anergic T cells that are triggered by their TCRs 
without an adequate co-stimulatory signal through CD28. 
Furthermore, several negative regulatory molecules involved 
in anergy induction, such as GRA IL and Egr2, were also 
up-regulated in W131AOT II CD4+ T cells. However, unlike 
clonal anergy resulting from incomplete T cell stimulation, 
no substantial differences were found on the surface expres-
sion of CD28 and CTLA-4 between OTII and W131AOT II 
mice (unpublished data). Alternatively, increased expression of 
inhibitory receptors observed in W131AOT II T cells is com-
monly seen in T cell exhaustion that often occurs in chronic 
viral infection and cancers (Crespo et al., 2013; Pauken and 
Wherry, 2015). Exhausted T cells in these settings progres-
sively lose their ability to produce effector cytokines and re-
tain their cytotoxic potential. Similarly, in W131AOT II mice, 
up-regulation of inhibitory receptors was first identified in 
the thymus, but T cell dysfunction became most obvious in 
the peripheral CD4+ T cells. It is possible that the negative 
regulatory mechanisms operative in T cell anergy and exhaus-
tion may all contribute toward the T cell hyporesponsiveness 
observed in W131AOT II mice.
Recently, it has been reported that CD4+ T cells under-
going clonal anergy induce high-level expression of CD73 
and FR4 (Kalekar et al., 2016). That study suggested that 
CD73hiFR4hi anergic T cells have the potential to become 
T reg cells in a lymphopenic environment. This conversion 
was suggested to be important for the avoidance of autoim-
munity, as removal of anergy-derived T reg cells results in the 
Figure 9. Anti–Pd-1 mAb treatment partially reverses t cell unresponsiveness in W131Aot II mice. Anti–PD-1 mAb or control IgG were adminis-
trated i.p. to 4-wk-old OTII or W131AOT II mice every other day for 3 wk to determine the role of PD-1 during anergy induction. Responses of naive CD4+ 
T cells were assessed by IL-2 production (top) and up-regulation of CD25 (middle) and CD69 (bottom) and. Data are representative of two independent 
experiments (n ≥ 4 per group). (B–D) Graphs depict the quantification of the results from A. Percentages of Il-2+ (B), CD25+ (C), and CD69+ (D) cells are 
shown. All error bars represent SEM. NS, not significant; *, P < 0.05; **, P < 0.01.
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development of autoimmunity. Similarly, we demonstrated 
a greater frequency of CD73hiFR4hi anergic T cell popula-
tion in antigen-experienced CD44 “high” non-T reg cells 
in W131AOT II mice as compared with OTII mice. Inter-
estingly, the CD73hiFR4hi anergic T cell population corre-
sponds to T cells with increased PD-1 expression. Although 
the roles of CD73 and FR4 in induction or maintenance 
of anergy process remain unclear, up-regulation of these two 
molecules in W131AOT II T cells supports the notion that 
W131OTII T cells acquire an anergic state in response to 
increased TCR signaling.
Unlike the anergic phenotype observed in W131AOT II 
mice described here, in a recent study, a combination of 
hypomorphic and autoinhibitory destabilizing mutations 
of ZAP70 in two affected children in a family led to early 
onset of several profound manifestations of autoimmunity 
(Chan et al., 2016). Although the difference between our 
mouse model and these patients could be due to the dif-
ferences in the impacts of each of the constitutively active 
ZAP70 mutations, it is likely that other genetic modifiers 
may also contribute to disease manifestations superimposed 
on the hypermorphic allele of ZAP70. In line with that, 
genome-wide association studies have uncovered many ge-
netic loci associated with autoimmune diseases (Hardy and 
Singleton, 2009). Each locus exerts a small effect on dis-
ease risk; however, combinations of genetic variants confer 
a graded risk of disease. The C57BL/6 mouse background 
into which the W131A mutation was introduced may not 
have a sufficient predisposition for autoimmunity. In contrast, 
the patients described by Chan et al. (2016), may have other 
genetic modifier loci that predispose them for autoimmu-
nity in the setting of increased ZAP70 activity. Moreover, 
recent identical twin studies highlighted the importance of 
environmental factors as key determinants of human autoim-
mune phenotypes (Imboden, 2009). Therefore, it is possible 
that W131AOT II mice reared in a specific pathogen–free 
facility lack the exposure to a variety of microbes that could 
influence the development of autoimmune diseases.
In summary, our findings provide some new insights 
into how inhibitory receptors function as rheostats that re-
strain inappropriate activation of TCR signaling throughout 
T cell development and link both central and peripheral tol-
erance mechanisms to keep potentially autoreactive T cells 
or T cells with inappropriately high TCR signaling in check. 
Our W131A mice may prove to be a useful genetic model to 
understand the complex inhibitory pathways that can impair 
or control T cell responses.
MAterIAlS And MetHodS
Generation of Zap70 W131A mice
Zap70 W131A knock-in mice were generated by a gene tar-
geting strategy. 1.7 kb of a 5′ homologous arm and 1.2 kb of a 
3′ homologous arm were generated by PCR from C57BL/6 
mouse genomic DNA. The 5′ homologous arm containing 
murine zap70 exon 2 and 3 was subjected to site-directed 
mutagenesis changing tryptophan 131 to alanine and simul-
taneously introducing a diagnostic Hind III site. The mutated 
5′ homologous arm and 3′ homologous arm was subcloned 
into a targeting vector containing Neo cassette floxed by the 
loxP sequence. The final targeting construct was confirmed 
by sequencing. Linearized DNA was electroporated into 
C57BL/6-derived embryonic stem (ES) cells (gift from A. Ma, 
University of California, San Francisco, San Francisco, CA). 
Homologous recombinants were selected in the presence of 
G418. DNA from each ES colony was first screened by ge-
nomic PCR using primers covering the neo gene and the 5′ 
homologous arm (Fig. 1 A, magenta arrowheads). Genomic 
DNA from potential ES clones was digested with EcoRI and 
analyzed by Southern blotting using the 5′ external probes 
shown in Fig.  1 A. Two positive clones with correctly tar-
geted alleles and knock-in mutations were also confirmed by 
sequencing and injected into C57BL/6 blastocysts. Chime-
ric mice were generated and mated with C57BL/6 females 
for germline transmission. The neo gene was further excised 
by crossing mutant mice to E2a Cre-tg mice obtained from 
The Jackson Laboratory. Excision of the neo gene was con-
firmed by genomic PCR. E2a cre-tg from the positive mu-
tant mice was removed by crossing several generations with 
C57BL/6 mice. Mice with the W131A allele and no cre-tg 
were intercrossed to obtain homozygous W131 mutant mice. 
The primers used for screening are as follows: 5′ primer, 
5′-CAT GAC CTG GAA GGA GGA CTTG-3′; 3′ primer, 5′-
TGG AGG AAC CTC TGT CAG CTC TAAG-3′. The size of 
the PCR product is 305 bp for the wild-type allele and 530 
bp for the W131A allele.
Mice
All mice were bred and maintained in a specific pathogen–
free facility and all studies were done according to the Insti-
tutional Animal Care and Use Committee guidelines of the 
University of California (San Francisco, CA). Lck-Bcl2 and 
Nur77-eGFP tg mice were described previously (Sentman 
et al., 1991; Zikherman et al., 2012). WT C57BL/6 OTII 
TCR tg mice were purchased from The Jackson Labora-
tory. Zap70+/−OTII and W131AOT II mice were generated 
in our laboratory by crossing OTII mice with Zap70−/− or 
W131A mice, respectively.
Antibodies
The following antibodies were used for staining: CD4 Per-
Cp-Cy5.5, TCRβ PerCp-Cy5.5, and CD62L APC (TON 
BO); CD44 FITC, PD-1 (29F.1A12) PE-Cy7, CD69 PE-
Cy7, CD5 PerCp-Cy5.5, CD8α Pacific Blue, and TCRβ Pa-
cific Blue (BioLegend); CD44 PE-Cy7, CD8α (APC-eFluor 
780), CD4 Qdot606, and Zap70 FITC (Life Technology). In 
vivo anti-PD (J43) antibody and control IgG were purchased 
from BioXcell. For intracellular flow cytometry, antibodies 
against phosphorylated ERKT202/Y204 (197G2), AKTThr308 
(C31E5E), and ribosomal protein S6Ser235/236 (D57.2.2E) were 
purchased from Cell Signaling Technology.
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t cell stimulation
For phospho-flow assays, thymocytes or magnetic bead neg-
atively purified peripheral CD4+T cells were rested in se-
rum-free medium for 30 min at 37°C, after which they were 
stimulated with 10 µg/ml of anti-CD3 (clone 2C11; Univer-
sity of California San Francisco [UCSF] Cell Culture Facility), 
followed by the addition of 50 ng/ml goat anti–Armenian 
hamster IgG (Jackson ImmunoResearch Laboratory) at 37°C 
for indicated times. For activation-induced cell death assays, 
such as intracellular Bim, thymocytes, or CD4+ T cells were 
stimulated with plate-bound anti-CD3 Ab (2C11; 10 µg/ml 
unless otherwise indicated) and 2 µg/ml anti-CD28 Ab (clone 
37.51; UCSF Cell Culture Facility) at 37°C for at least 16 h.
Intracellular staining
For phospho-ERK, -AKT, and -S6 staining, assays were per-
formed as previously described (Hsu et al., 2009). Foxp3 and 
Egr2 staining was performed using the Foxp3 Staining Buffer 
Set (eBioscience). For intracellular staining of Bim, thymo-
cytes were stimulated as described as in the preceding section 
and stained for surface markers before permeabilization using 
the Cytofix/Cytoperm kit (BD). Permeabilized cells were 
then stained with anti-Bim (clone C34C5) antibodies (Cell 
Signaling Technology), followed by staining with donkey anti–
rabbit IgG-APC (Jackson ImmunoResearch Laboratory).
calcium flux
Thymocytes or purified CD4+ T cells from either OTII or 
W131AOT II mice were first surface-stained with anti–
CD45.2-FITC and anti–CD45.2-PE, respectively, for subse-
quent identification of the two genotypes. Cells from both 
genotypes were mixed together, loaded with Indo-1 dye (In-
vitrogen) for 30 min at 37°C in RPMI medium plus 5% fetal 
bovine serum. After loading with Indo-1, cells were stained 
with CD4, CD8, Vα2, CD25, and TCRβ (for thymocytes) 
and CD44 (for peripheral T cells). Finally, cells were analyzed 
by flow cytometry (LSRFortessa [BD] with a UV laser) at 
37°C and stimulated with 10 µg/ml anti-CD3, followed by 
cross-linking with 50 ng/ml goat anti–Armenian hamster 
IgG. Calcium increase was monitored as the ratio of Indo-1 
(blue) and (violet) and displayed as a function of time.
Quantitative rt-Pcr
Total RNA was purified using the RNeasy Micro kit (QIA 
GEN). cDNA was synthesized using Superscript III First-
Strand Synthesis System (Invitrogen) according to the man-
ufacturer’s instructions. To measure the E3 ubiquitin ligase, 
GRA IL transcript level, TaqMan Real-Time PCR was per-
formed using TaqMan Real-Time PCR Master Mix (Invi-
trogen) and TaqMan primer (primer 1: 5′-GCC AAT TTC 
CTT GTC TCC TTG-3′, primer 2: 5′-CTG CTC GAA GAT 
TAC GAA ATGC-3′), and probe: 5′-/56-FAM/ACT GCC 
TCT/ZAN/GCT TCC TGC TTT GA/31ABkFQ/-3′ were 
purchased from IDT. An ABI Quantstudio machine (Applied 
Biosystems) was used for all quantitative PCR assays. The rela-
tive abundance of all target genes was normalized to the abun-
dance of an internal reference gene (β2 microglobulin; β2m).
cd69 up-regulation and Il-2 secretion assay
Sorted naive CD4+OTII+ T cells (CD4+CD62LhiCD44lo 
CD25−Vα2+) were stimulated for 16  h at 37°C by TCR 
Cα−/− splenocytes preincubated with 1  µM OVA peptide. 
After overnight stimulation, IL-2–secreting CD4+ T cells 
were identified using the IL-2 secretion assay (Miltenyi Bio-
tec) according to the instructions of the manufacturer. In 
brief, cells were harvested and washed after stimulation, la-
beled with anti–IL-2 affinity matrix and incubated at 37°C 
with warm medium for 45 min. Captured IL-2, as well as 
CD69 and CD25 activation markers, were then detected 
simultaneously by flow cytometry with anti–IL-2-PE and 
anti-CD69, anti-CD25 antibody staining.
Bone marrow chimeras
Mixed bone marrow chimera was generated as previously de-
scribed (Phee et al., 2010). In brief, equal numbers of T cell–
depleted bone marrow cells from OTII (CD45.1+CD45.2+) 
and W131AOT II (CD45.2+) mice were co-transferred into 
lethally irradiated BoyJ (CD45.1) recipient mice, and ana-
lyzed 8 wk post-transfer.
oVA immunization
Cell labeling and footpad injection were performed as previ-
ously described (Au-Yeung et al., 2014).
Anti–Pd-1 mAb treatment
Treatment was performed as previously described (Fife et al., 
2006). In brief, 4-wk-old OTII and W131AOT II mice were 
treated i.p. with 500 µg anti–PD-1 or control IgG on day 1 
and with 250 µg every other day for 3 wk.
Statistical analysis
Unpaired two-tailed Student’s t tests were performed to de-
termine statistical significance between two groups.
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